<?xml version="1.0" encoding="UTF-8"?>
<ref id="B13-marinedrugs-17-00567">
 <label>13.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meuleman</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Albecka</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Belouzard</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Vercauteren</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Verhoye</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Wychowski</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Leroux-Roels</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Palmer</surname>
    <given-names>K.E.</given-names>
   </name>
   <name>
    <surname>Dubuisson</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>Griffithsin has antiviral activity against hepatitis C virus</article-title>
  <source>Antimicrob. Agents Chemother.</source>
  <year>2011</year>
  <volume>55</volume>
  <fpage>5159</fpage>
  <lpage>5167</lpage>
  <pub-id pub-id-type="doi">10.1128/AAC.00633-11</pub-id>
  <?supplied-pmid 21896910?>
  <pub-id pub-id-type="pmid">21896910</pub-id>
 </element-citation>
</ref>
